<i>In Vitro</i> Activity of Finafloxacin against Panels of Respiratory Pathogens
This study determined the <i>in vitro</i> activity of finafloxacin against panels of bacterial strains, representative of those associated with infection in cystic fibrosis patients and predominately isolated from clinical cases of respiratory disease. Many of these isolates were resista...
Saved in:
Main Authors: | Sarah V. Harding (Author), Kay B. Barnes (Author), Stephen Hawser (Author), Christine E. Bentley (Author), Andreas Vente (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Delafloxacin, Finafloxacin, and Zabofloxacin: Novel Fluoroquinolones in the Antibiotic Pipeline
by: Béla Kocsis, et al.
Published: (2021) -
<i>In Vitro</i> Activity of Novel Topoisomerase Inhibitors against <i>Francisella tularensis</i> and <i>Burkholderia pseudomallei</i>
by: Adam O. Whelan, et al.
Published: (2023) -
An Investigation into the Re-Emergence of Disease Following Cessation of Antibiotic Treatment in Balb/c Mice Infected with Inhalational <i>Burkholderia pseudomallei</i>
by: Thomas R. Laws, et al.
Published: (2022) -
In Vitro and In Vivo Antimicrobial Activity of the Novel Peptide OMN6 against Multidrug-Resistant <i>Acinetobacter baumannii</i>
by: Janna Michaeli, et al.
Published: (2022) -
Virucidal and virostatic in vitro activity of ELOM-080 against respiratory pathogens
by: Jörn Thomsen, et al.
Published: (2021)